INGA BUFANO: Open Payments
NPI 1437185345 · CLARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 38 payments from 16 companies in 2025. Trend: 2023 $1,103 · 2024 $1,092 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| PFIZER INC. | 4 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $54 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| Organon LLC | 3 | $37 |
| Incyte Corporation | 2 | $36 |
| Botanix SB Inc | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $33 |
| STRATA Skin Sciences, Inc. | 3 | $25 |
Products named: COSENTYX, CIBINQO, BLU-U, VTAMA, OPZELURA, SOFDRA, DUPIXENT, XTRAC.
Industry payments across NJ — which companies pay providers there.
